Basket | Login | Register


New JPND project EUROFINGERS kicks off

Wednesday 11 March 2020

On 11 March, the new JPND-funded project EUROFINGERS, kicked off in an online meeting. This replaced a planned face-to-face meeting in Stockholm which could not take place due to current restrictions in travelling in Europe. All partners of the consortium actively participated in the online kick-off meeting which is led by the Karolinska Institute (Sweden). Over the next three years, EUROFINGERS will, by means of a precision medicine approach, work on the topic of the prevention of Alzheimer’s disease (AD) and will build on the work of similar existing European studies. During the kick-off meeting representatives from the different work packages in the project presented and briefly discussed their planned work including amongst other activities the development of (1) a model which will help to identify people at higher risk of developing AD dementia who may be more likely to benefit from targeted preventative interventions and (2) online registries in different countries in Europe. Alzheimer Europe (AE) will be involved in the Patient and Public Involvement (PPI) activities of the project and in this context, will set up a Patient Advisory Board to provide relevant input to the researchers from the perspective of people with Alzheimer’s disease across the disease continuum. AE will also co-lead the communication activities of the project, particularly the communication of the project activities and results to lay audiences and people affected by AD. Jean, Dianne and Ana took part in the meeting. Alzheimer Europe’s participation is supported by the Luxembourg national research Fund (FNR).

Eurofingers is an EU Joint Programme - Neurodegenrative Disease Research (JPND) project and is supported by the Luxembourg national research Fund (FNR). The project code is INTER/JPND/19/BM/14012609.